7thSpace Interactive (press release) During the treatment, the cough sensitivity to saline gradually decreased among the budesonide responders but not in the non-responders. Nitric oxide levels decreased very rapidly among the responders. Conclusions: Saline test cannot predict the ...
EON: Enhanced Online News (press release) Budesonide foam, RELISTOR® , LUMACAN™ and rifaximin for additional indications are under development. For full prescribing information and important safety information on Salix products, including BOXED WARNINGS for OSMOPREP, AZASAN and ...
Seeking Alpha In the first quarter we launched the product mid-February. We reported $6.6 million of sales. We've gotten excellent reception for this product for a couple of reasons. Number one, they're very familiar with budesonide . Budesonide has been around for a ... and more »
PharmiWeb.com (press release) Budesonide foam RELISTOR¬ÆLUMACAN‚Ñ¢ and rifaximin for additional indications are under development. For full prescribing information and important safety information on Salix products including BOXED WARNINGS for OSMOPREP AZASAN and ... and more »
The Pharma Letter Similarly, the fluticasone/salmeterol treatment group was associated with 74% higher pneumonia-related hospital admissions than the budesonide /formoterol treatment group (RR 1.74 [95% CI 1.56-1.94]; p ...
NASDAQ Salix Pharmaceuticals, Ltd. ( SLXP ) recently announced positive data from two late-stage studies conducted with budesonide foam for the treatment of active mild to moderate ulcerative proctitis (UP) or ulcerative proctosigmoiditis (UPS). Results from ... and more »
DailyFinance Clostridium difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents , including XIFAXAN, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal ...
7thSpace Interactive (press release) During the treatment, the cough sensitivity to saline gradually decreased among the budesonide responders but not in the non-responders. Nitric oxide levels decreased very rapidly among the responders. Conclusions: Saline test cannot predict the ...
7thSpace Interactive (press release) During the treatment, the cough sensitivity to saline gradually decreased among the budesonide responders but not in the non-responders. Nitric oxide levels decreased very rapidly among the responders. Conclusions: Saline test cannot predict the ...
Zacks.com AstraZeneca (AZN - Analyst Report) recently announced that the US Court of Appeals for the Federal Circuit has issued a temporary injunction related to the distribution of generic versions of Pulmicort Respules ( budesonide inhalation suspension) in the US. and more »
